TUMOR INFILTRATING LYMPHOCYTE
Clinical trials for TUMOR INFILTRATING LYMPHOCYTE explained in plain language.
Never miss a new study
Get alerted when new TUMOR INFILTRATING LYMPHOCYTE trials appear
Sign up with your email to follow new studies for TUMOR INFILTRATING LYMPHOCYTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cells from tumors could be new weapon against Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment for people with advanced liver or pancreatic cancers that have not responded to standard therapies. The treatment uses immune cells taken from the patient's own tumor, grown in large numbers in a lab, and then given back to the patient. The goal i…
Matched conditions: TUMOR INFILTRATING LYMPHOCYTE
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 17, 2026 02:15 UTC
-
Immune cells supercharged to fight advanced skin cancer
Disease control Recruiting nowThis study tests a treatment made from a patient's own immune cells (called TILs) to fight advanced melanoma. Doctors take a sample of the tumor, grow the immune cells in a lab, and then put them back into the patient. The goal is to shrink tumors and control the cancer, but pati…
Matched conditions: TUMOR INFILTRATING LYMPHOCYTE
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:05 UTC